DYN

Dyne Therapeutics Inc.

Price

$26.78

return (12m)

118.61%

p/e

-8.12

p/bv

6.01

DIVIDEND YIELD

0.00%

DYN price

Dyne Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment DYN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

11.93%

3 months

54.17%

1 year

118.61%

2 years

-41.93%

5 years

66.44%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals DYN

Valuation

P/E

-8.12

Sector -4.38

Industry -4.38

P/BV

6.01

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector -4.40

Industry -4.40

EV/EBITDA

-20.29

Sector -263.09

Industry -263.09

EV/EBIT

-20.22

Sector -702.90

Industry -702.90

P/EBITDA

-8.40

Sector -4.39

Industry -4.39

P/EBIT

-8.36

Sector -4.73

Industry -4.73

P/Total Assets

4.24

Sector 1.49

Industry 1.49

P/Net Current Assets

6.53

Sector -11.70

Industry -11.70

P/Working Capital

4.90

Sector -3.19

Industry -3.19

EPS

-3.15

Sector -2.14

Industry -2.14

BVPS

4.26

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

0.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

0.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

0.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-73.97%

Sector -65.14%

Industry -65.14%

ROA

-52.25%

Sector -65.53%

Industry -65.53%

ROIC

-996.62%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

12.02

Sector 2.90

Industry 2.90

Net Debt / EBITDA

4.03

Sector -6.07

Industry -6.07

Net Debt / EBIT

4.02

Sector -8.26

Industry -8.26

Net Debt / Equity

-1.00

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.28

Sector -0.05

Industry -0.05

Equity/Assets

0.71

Sector 0.41

Industry 0.41

Liabilities/Assets

0.29

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

28.32%

Sector -

Industry -

Fundamentals DYN

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
DYN Dyne Therapeutics Inc.	$26.78	117.19%	0.00%	-8.12	6.01	-73.97%	0.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

DYN Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Dyne Therapeutics

Dyne Therapeutics Inc.

Average Investor10 user rating

4.0 (1 people)

United States

9 years

Founded: 2017

2020

Time since IPO - 6 years

47

Employees

Dyne Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $4.22 billion, with shareholders equity totaling $702.15 million.

The company employs approximately 47 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Dyne Therapeutics Inc. reported $- in revenue, generating net income of $-519.40 million.

Key financial metrics include a P/E ratio of -8.12, a price-to-book (P/B) ratio of 6.01, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker DYN.

Market cap

$4.22 billion

Net worth

$702.15 million

$702,150,000.00

Assets

$994.01 million

$994,010,000.00

Total Shares Outstanding

165.00 million

165,000,000

Average Daily Trading Volume

$2.39 million

$2,392,160.00

Sector

Health Care

Industry

Biotechnology

DYN

DYN revenue and profits

Financial Results DYN

DRAG THE FRAME TO SEE MORE DATA

DYN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Dyne Therapeutics (DYN) today?

A cotação de Dyne Therapeutics (DYN) hoje está em US$ 26.78, com uma variação de 118.61% em relação ao último ano. A cotação de Dyne Therapeutics (DYN) iniciou o ano negociando na casa dos US$ 19.56 e hoje está em US$ 26.78. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Dyne Therapeutics (DYN) e dados de ações do Ibovespa e mercados internacionais.

Quando Dyne Therapeutics (DYN) paga dividendos?

Dyne Therapeutics (DYN) não distribuiu dividendos no último ano.

Is Dyne Therapeutics (DYN) a good investment?

Atualmente, Dyne Therapeutics (DYN) está cotada a US$ 26.78, com um P/L de -8.12, representando um desvio de -584% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 118.61 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 118.61%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Dyne Therapeutics (DYN) stock?

Investir em ações de Dyne Therapeutics (DYN) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Dyne Therapeutics (DYN) yield today?

A rentabilidade de Dyne Therapeutics (DYN) foi de 11.93% no último mês, 118.61% no último ano e 66.44% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Dyne Therapeutics (DYN) hoje, o investimento total seria de US$ 2,678.00, com base na cotação atual de US$ 26.78.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 5,854.38
Em 5 anos: US$ 4,457.26
Em 10 anos: US$ 2,678.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

DYN

Dyne Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment DYN

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING DYN WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Dyne Therapeutics

Dyne Therapeutics Inc.

United States

9 years

2020

47

PROFIT X PRICE DYN

Financial Results DYN

DYN cash flow

Asset, Revenue and Profit Growth - DYN

DYN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions